A new Kunitz-type plasmin inhibitor from scorpion venom. (November 2015)

• Record Type: Journal Article
• Authors: Ding, Li; Wang, Xiaobo; Liu, Hongyan; San, Mingkui; Xu, Yue; Li, Jian; Li, Shan; Cao, Zhijian; Li, Wenxin; Wu, Yingliang; Chen, Zongyun
• Is Part Of: Toxicon. Volume 106(2015)
• Page Start: 7
• Page End: 13
• Publication Date: 2015-11
• Subjects: Plasmin -- BmKTT-2 -- Peptide inhibitor -- Kunitz-type -- Scorpion venom; Toxins -- Periodicals; Venom -- Periodicals; 615.9
• DOI: 10.1016/j.toxicon.2015.09.004
• Languages: English
• ISSNs: 0041-0101

Abstract

Abstract: Kunitz-type peptides from venomous animals are an important source of lead drug candidates towards human plasmin, a target of protease-associated diseases. However, no Kunitz-type plasmin inhibitor from venomous scorpion has been characterized. Here, we first investigated plasmin inhibiting activities of eight known Kunitz-type scorpion toxins Hg1, BmKTT-1, BmKTT-2, BmKTT-3, LmKTT-1a, LmKTT-1b, LmKTT-1c and BmKPI, and found a new plasmin inhibitor BmKTT-2, a Kunitz-type toxin peptide from the scorpion Buthus martensi karch . Protease inhibitory activity assay showed that BmKTT-2 potently inhibited plasmin with a Ki value of 8.75 ± 2.05 nM. Structure–function relationship studies between BmKTT-2 and plasmin showed that BmKTT-2 is a classical Kunitz-type plasmin inhibitor: Lys13 in BmKTT-2 is the P1 site, and Ala14 in BmKTT-2 is the P1′ site. Interestingly, BmKTT-2 has potent inhibiting activities towards three important digestive serine proteases trypsin, chymotrypsin and elastase, suggesting a good stability for administering oral medications. To the best of our knowledge, BmKTT-2 is the first Kunitz-type human plasmin inhibitor from scorpion venom, providing novel insights into drug developments targeting human plasmin protease. Highlights: No Kunitz-type plasmin inhibitor from venomous scorpion has been characterized. We found a Kunitz-type plasmin inhibitor BmKTT-2 from the scorpion Buthus martensi karch with a Ki value of 8.75 ± 2.05 nM. BmKTT-2 has potent inhibiting activities towards three digestive serine proteases trypsin, chymotrypsin and elastase. BmKTT-2 is the first Kunitz-type plasmin inhibitor from scorpion venom.